Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo

Naoyuki Danbara, Takashi Yuri, Miki Tsujita-Kyutoku, Reiko Tsukamoto, Norihisa Uehara, Airo Tsubura

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: The mammalian lignan enterolactone (ENL) is produced from plant lignans which are present in large amounts in flaxseed (linseed). The effect of ENL on colon cancer cell growth in vitro and in vivo, and its mechanisms of action, have not been studied in detail. Materials and Methods: The growth of the colo 201 human colon cancer cell line was examined by colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl) -2H-tetrazolium (MTS) assay, while the expression of apoptosis- and proliferation-related proteins (p53, Bax, Bcl-xL and S, Bcl-2, Caspase-8, Caspase-3 and proliferating cell nuclear antigen (PCNA)) were examined by Western blotting. In vivo tumor growth was examined by transplanting colo 201 cells into ENL-treated and placebo-treated athymic mice. Results: The MTS assay showed that ENL suppressed colo 201 cell growth (IC50 for 72 h: 118.4 μM) in vitro. On flow cytometry, induction of apoptosis was confirmed by the appearance of subG1 populations, while cell cycle progression was not affected. The expression of an apoptosis-suppressing protein (Bcl-2) was down-regulated, an apoptosis-enhancing protein (cleaved form of Caspase-3) was up-regulated, proliferation-related PCNA protein was down-regulated and p53, Bax, Bcl-xL and S and Caspase-8 levels were unchanged. ENL, at a dose of 10 mg/kg given 3 times per week by subcutaneous injection, significantly inhibited the growth of colo 201 cells transplanted into athymic mice without any adverse effects. Conclusion: ENL suppressed colo 201 human colon cancer cell growth both in vitro and in vivo. The tumor-suppressing mechanisms included apoptosis and decreased cell proliferation.

Original languageEnglish
Pages (from-to)2269-2276
Number of pages8
JournalAnticancer Research
Volume25
Issue number3 B
Publication statusPublished - May 2005
Externally publishedYes

Fingerprint

Colonic Neoplasms
Apoptosis
Growth
Flax
Lignans
Caspase 8
Proliferating Cell Nuclear Antigen
Nude Mice
Caspase 3
bcl-2-Associated X Protein
Subcutaneous Injections
Nuclear Proteins
Inhibitory Concentration 50
2,3-bis(3'-hydroxybenzyl)butyrolactone
In Vitro Techniques
Neoplasms
Cell Cycle
Flow Cytometry
Proteins
Western Blotting

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Danbara, N., Yuri, T., Tsujita-Kyutoku, M., Tsukamoto, R., Uehara, N., & Tsubura, A. (2005). Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Research, 25(3 B), 2269-2276.

Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo. / Danbara, Naoyuki; Yuri, Takashi; Tsujita-Kyutoku, Miki; Tsukamoto, Reiko; Uehara, Norihisa; Tsubura, Airo.

In: Anticancer Research, Vol. 25, No. 3 B, 05.2005, p. 2269-2276.

Research output: Contribution to journalArticle

Danbara, N, Yuri, T, Tsujita-Kyutoku, M, Tsukamoto, R, Uehara, N & Tsubura, A 2005, 'Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo', Anticancer Research, vol. 25, no. 3 B, pp. 2269-2276.
Danbara, Naoyuki ; Yuri, Takashi ; Tsujita-Kyutoku, Miki ; Tsukamoto, Reiko ; Uehara, Norihisa ; Tsubura, Airo. / Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo. In: Anticancer Research. 2005 ; Vol. 25, No. 3 B. pp. 2269-2276.
@article{e5304812c6e6475ba9184accacf5f43c,
title = "Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo",
abstract = "Background: The mammalian lignan enterolactone (ENL) is produced from plant lignans which are present in large amounts in flaxseed (linseed). The effect of ENL on colon cancer cell growth in vitro and in vivo, and its mechanisms of action, have not been studied in detail. Materials and Methods: The growth of the colo 201 human colon cancer cell line was examined by colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl) -2H-tetrazolium (MTS) assay, while the expression of apoptosis- and proliferation-related proteins (p53, Bax, Bcl-xL and S, Bcl-2, Caspase-8, Caspase-3 and proliferating cell nuclear antigen (PCNA)) were examined by Western blotting. In vivo tumor growth was examined by transplanting colo 201 cells into ENL-treated and placebo-treated athymic mice. Results: The MTS assay showed that ENL suppressed colo 201 cell growth (IC50 for 72 h: 118.4 μM) in vitro. On flow cytometry, induction of apoptosis was confirmed by the appearance of subG1 populations, while cell cycle progression was not affected. The expression of an apoptosis-suppressing protein (Bcl-2) was down-regulated, an apoptosis-enhancing protein (cleaved form of Caspase-3) was up-regulated, proliferation-related PCNA protein was down-regulated and p53, Bax, Bcl-xL and S and Caspase-8 levels were unchanged. ENL, at a dose of 10 mg/kg given 3 times per week by subcutaneous injection, significantly inhibited the growth of colo 201 cells transplanted into athymic mice without any adverse effects. Conclusion: ENL suppressed colo 201 human colon cancer cell growth both in vitro and in vivo. The tumor-suppressing mechanisms included apoptosis and decreased cell proliferation.",
author = "Naoyuki Danbara and Takashi Yuri and Miki Tsujita-Kyutoku and Reiko Tsukamoto and Norihisa Uehara and Airo Tsubura",
year = "2005",
month = "5",
language = "English",
volume = "25",
pages = "2269--2276",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 B",

}

TY - JOUR

T1 - Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo

AU - Danbara, Naoyuki

AU - Yuri, Takashi

AU - Tsujita-Kyutoku, Miki

AU - Tsukamoto, Reiko

AU - Uehara, Norihisa

AU - Tsubura, Airo

PY - 2005/5

Y1 - 2005/5

N2 - Background: The mammalian lignan enterolactone (ENL) is produced from plant lignans which are present in large amounts in flaxseed (linseed). The effect of ENL on colon cancer cell growth in vitro and in vivo, and its mechanisms of action, have not been studied in detail. Materials and Methods: The growth of the colo 201 human colon cancer cell line was examined by colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl) -2H-tetrazolium (MTS) assay, while the expression of apoptosis- and proliferation-related proteins (p53, Bax, Bcl-xL and S, Bcl-2, Caspase-8, Caspase-3 and proliferating cell nuclear antigen (PCNA)) were examined by Western blotting. In vivo tumor growth was examined by transplanting colo 201 cells into ENL-treated and placebo-treated athymic mice. Results: The MTS assay showed that ENL suppressed colo 201 cell growth (IC50 for 72 h: 118.4 μM) in vitro. On flow cytometry, induction of apoptosis was confirmed by the appearance of subG1 populations, while cell cycle progression was not affected. The expression of an apoptosis-suppressing protein (Bcl-2) was down-regulated, an apoptosis-enhancing protein (cleaved form of Caspase-3) was up-regulated, proliferation-related PCNA protein was down-regulated and p53, Bax, Bcl-xL and S and Caspase-8 levels were unchanged. ENL, at a dose of 10 mg/kg given 3 times per week by subcutaneous injection, significantly inhibited the growth of colo 201 cells transplanted into athymic mice without any adverse effects. Conclusion: ENL suppressed colo 201 human colon cancer cell growth both in vitro and in vivo. The tumor-suppressing mechanisms included apoptosis and decreased cell proliferation.

AB - Background: The mammalian lignan enterolactone (ENL) is produced from plant lignans which are present in large amounts in flaxseed (linseed). The effect of ENL on colon cancer cell growth in vitro and in vivo, and its mechanisms of action, have not been studied in detail. Materials and Methods: The growth of the colo 201 human colon cancer cell line was examined by colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl) -2H-tetrazolium (MTS) assay, while the expression of apoptosis- and proliferation-related proteins (p53, Bax, Bcl-xL and S, Bcl-2, Caspase-8, Caspase-3 and proliferating cell nuclear antigen (PCNA)) were examined by Western blotting. In vivo tumor growth was examined by transplanting colo 201 cells into ENL-treated and placebo-treated athymic mice. Results: The MTS assay showed that ENL suppressed colo 201 cell growth (IC50 for 72 h: 118.4 μM) in vitro. On flow cytometry, induction of apoptosis was confirmed by the appearance of subG1 populations, while cell cycle progression was not affected. The expression of an apoptosis-suppressing protein (Bcl-2) was down-regulated, an apoptosis-enhancing protein (cleaved form of Caspase-3) was up-regulated, proliferation-related PCNA protein was down-regulated and p53, Bax, Bcl-xL and S and Caspase-8 levels were unchanged. ENL, at a dose of 10 mg/kg given 3 times per week by subcutaneous injection, significantly inhibited the growth of colo 201 cells transplanted into athymic mice without any adverse effects. Conclusion: ENL suppressed colo 201 human colon cancer cell growth both in vitro and in vivo. The tumor-suppressing mechanisms included apoptosis and decreased cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=21344468602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344468602&partnerID=8YFLogxK

M3 - Article

C2 - 16158974

AN - SCOPUS:21344468602

VL - 25

SP - 2269

EP - 2276

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 B

ER -